Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer

NCT00209092 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Docetaxel
DRUG: Capecitabine

Sponsor

Emory University

Collaborators

[object Object]
[object Object]